Average Co-Inventor Count = 3.27
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (7 from 666 patents)
2. Orsenix Holdings Bv (3 from 3 patents)
3. Incyte Holdings Corporation (2 from 147 patents)
10 patents:
1. 10653628 - High surface-area lyophilized compositions comprising arsenic for oral administration in patients
2. 10272045 - High surface-area lyophilized compositions comprising arsenic for oral administration in patients
3. 10111836 - High surface-area lyophilized compositions comprising arsenic for oral administration in patients
4. 9345677 - Compositions, methods and kits relating to HER-2 cleavage
5. 9206187 - Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase
6. 8946245 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
7. 8933086 - Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors
8. 8541425 - Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
9. 8088737 - Compositions, methods and kits relating to Her-2 cleavage
10. 7910108 - Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases